Sleep Supplements: What Actually Works — An Evidence-Based Review

Melatonin is the most widely used sleep supplement in the United States, with millions of Americans taking it nightly. Yet it is also one of the most misunderstood. Most consumers take doses that are unnecessarily high, use it for sleep problems it does not effectively treat, and have absorbed marketing messages that bear little resemblance to the clinical evidence.

Melatonin is not a sleeping pill. It does not initiate sleep, does not keep you asleep, and does not work through sedation. It is a chronobiotic — a circadian rhythm regulator — that signals to your brain that darkness has arrived and sleep should be initiated. Understanding this distinction transforms how you should think about dosing, timing, and when melatonin is — and is not — the right choice.

What Is Melatonin?

The Hormone of Darkness

Melatonin is a hormone produced by the pineal gland, a tiny structure deep in the brain. Its synthesis and release follow a strict circadian pattern:

· **Daytime**: Light exposure (particularly blue light) suppresses melatonin production via signals from the suprachiasmatic nucleus (SCN) — the brain's master clock

· **Evening**: As light decreases, the SCN signals the pineal gland to convert serotonin to melatonin through a two-step enzymatic process

· **Night**: Melatonin levels peak in the middle of the night, typically between 2:00 AM and 4:00 AM

· **Morning**: Light exposure suppresses melatonin, levels drop to near-zero during daylight hours

The Signal, Not the Sedative

Melatonin does not directly induce sleep in the way that a benzodiazepine, Z-drug, or antihistamine does. Rather, it provides the internal signal that it is nighttime — opening the "gate" for sleep to occur. This is a crucial distinction:

What Melatonin Actually Helps

Circadian Rhythm Disorders (Strong Evidence)

This is where melatonin shines. The American Academy of Sleep Medicine's clinical practice guideline recognizes melatonin as effective for:

Jet Lag: Melatonin taken close to the target bedtime at the destination can advance or delay the circadian clock to match the new time zone. A Cochrane Review of 10 trials found melatonin highly effective for preventing or reducing jet lag, with 0.5–5 mg taken at bedtime at the destination.

Delayed Sleep Phase Syndrome (DSPS): Individuals with DSPS have a circadian clock that runs later than social norms — they cannot fall asleep until 2:00–4:00 AM. Low-dose melatonin (0.3–1.0 mg) taken 4–6 hours before their natural sleep onset can advance the circadian clock and normalize sleep timing over weeks.

Shift Work Sleep Disorder: Evidence is more mixed than for jet lag and DSPS. The challenge is that the circadian misalignment in shift work is profound, and melatonin's effects are modest by comparison. It may provide some benefit, but expectations should be tempered.

General Insomnia (Modest Evidence)

For general insomnia — where circadian rhythm is not the primary issue — melatonin's effects are more modest. The 2013 PLOS ONE meta-analysis of 19 trials found:

· Sleep onset latency reduced by 7 minutes (statistically significant but clinically modest)

· Total sleep time increased by 8 minutes

· Sleep quality modestly improved

For comparison, prescription sleep medications reduce sleep onset latency by 10–30 minutes on average. Melatonin is not in the same pharmacological category.

Other Evidence-Supported Uses

The Dosage Problem

How Much Is Right?

The most common retail doses of melatonin (3 mg, 5 mg, 10 mg) are pharmacological doses — they produce blood levels far exceeding what the body naturally produces. The pineal gland secretes approximately 10–80 micrograms (0.01–0.08 mg) of melatonin per night. A 3 mg supplement is 30–300 times the physiological dose.

Research by Richard Wurtman at MIT in the early 2000s established that the optimal dose for sleep onset lies in the 0.3–1.0 mg range:

· A 2001 study in the *Journal of Clinical Endocrinology & Metabolism* compared 0.3 mg and 3.0 mg and found both equally effective for sleep onset, but the 3.0 mg dose produced supraphysiological blood levels that persisted into the following morning.

· A 2005 study confirmed that lower doses produce more physiological blood concentrations without sacrificing efficacy.

Why Manufacturers Sell High Doses

The high-dose melatonin market is largely a historical accident. The original MIT patent covered low-dose melatonin (0.3–1.0 mg), and to bypass the patent, supplement manufacturers produced doses outside the patented range — hence the proliferation of 3 mg, 5 mg, and 10 mg products. Marketing then positioned "more = more effective," which the evidence does not support.

Dosing by Purpose

Important: If you are using a standard 3 mg tablet, splitting it into quarters provides approximately 0.75 mg per piece — a dose better aligned with the evidence.

Melatonin Safety Profile

A Favorable Safety Record

Melatonin has an excellent short-to-medium-term safety profile. Adverse events in clinical trials are generally mild and comparable to placebo:

Long-Term Safety

Most clinical trials of melatonin have been short-to-medium term (weeks to months). Long-term safety data beyond 2 years of daily use is limited. However, epidemiological studies of shift workers using melatonin for extended periods have not revealed significant safety concerns, and the physiological nature of melatonin (a naturally produced hormone) suggests a different risk profile than synthetic sedatives.

Populations Requiring Caution

Melatonin vs. Other Sleep Interventions

FAQ

Q1: Is it safe to take melatonin every night?

Short-to-medium-term nightly use (months to a year) appears safe. Long-term data beyond 2 years is limited. Ideally, melatonin should be used as a bridge while developing behavioral sleep skills, with periodic reassessment of whether continued use is necessary.

Q2: Can I become dependent on melatonin?

Physical dependence (withdrawal upon cessation) has not been demonstrated for melatonin, unlike benzodiazepines or Z-drugs. Psychological reliance is possible — the belief that you cannot sleep without it — and can be addressed by gradually reducing the dose or using it intermittently.

Q3: Does melatonin make you groggy the next morning?

If you experience morning grogginess, your dose is almost certainly too high. Reducing from 3–10 mg to 0.3–1.0 mg typically eliminates next-day effects. Extended-release formulations may also cause more carryover effects than immediate-release products.

Q4: Can I take melatonin with alcohol?

Combining melatonin with alcohol is not recommended. Alcohol fragments sleep architecture and reduces REM sleep, counteracting the purpose of sleep optimization. Additionally, alcohol may alter melatonin metabolism and increase side effects.

Q5: Is melatonin safe for teenagers?

Melatonin has been studied in adolescents and appears reasonably safe in the short term at appropriate doses (0.5–3 mg). The primary concern in teenagers is not directly melatonin-related but behavioral — adolescents typically have a physiologically delayed circadian rhythm, and the best intervention is often delaying school start times and managing screen time rather than supplementation.

Q6: Does melatonin suppress natural production?

The evidence to date suggests that exogenous melatonin does not suppress endogenous production in a clinically meaningful way. The feedback inhibition, if present, is mild. This is an area of ongoing research, and the long-term implications of exogenous melatonin on pineal function are not fully characterized.

Q7: What is the difference between immediate-release and extended-release melatonin?

Immediate-release melatonin helps with sleep onset (falling asleep). Extended-release melatonin is designed to maintain melatonin levels through the night, potentially helping with sleep maintenance (staying asleep). For most people, immediate-release is appropriate; extended-release may be helpful for those who fall asleep easily but wake frequently.

Q8: Can melatonin help with anxiety?

Some evidence suggests melatonin may modestly reduce preoperative and general anxiety through GABA-ergic and antioxidant mechanisms. For anxiety-specific applications, dose ranges are typically higher (3–5 mg) than those used for sleep. L-theanine, ashwagandha, and magnesium are more directly indicated for anxiety.

Conclusion

Melatonin is an effective, safe, and affordable tool — when used for the right reasons and at the right dose. For circadian rhythm disruption — jet lag, shift work, delayed sleep phase — it is genuinely helpful and well-supported by evidence. For general insomnia, its effects are modest, and expectations should be calibrated accordingly.

The single most actionable piece of information in this article may be the dose: 0.3 to 1.0 mg, not the 3 mg, 5 mg, or 10 mg that dominates retail shelves. Lower doses produce physiological blood levels, work as well as higher doses for sleep onset, and eliminate the morning grogginess that leads many people to abandon melatonin.

At well&whole, we believe in getting the basics right — and in the case of melatonin, the basic that most people get wrong is the dose. Our Sleep Support Collection includes melatonin at evidence-aligned doses because your circadian rhythm deserves precision, not megadosing.